Archive: 25/09/2015

Tumor necrosis factor in colitis—bad actor or hero?

Investigators at Children's Hospital Los Angeles have found that a common therapeutic target for the treatment of inflammatory bowel disease (IBD) may actually protect against intestinal inflammation by inhibiting pathogenic ...

page 3 from 7